Rallybio

IPO

Unimagined Therapies. Undreamed Outcomes.

Public · New Haven, United States · Founded 2018 · $182.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$182.0M
Last Round
$145.0M Series BMay 2020
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Rallybio is a clinical-stage biotechnology company advancing therapies for patients with severe and rare diseases, focused on complement dysregulation and hematology. The company combines deep drug development expertise with a global network of academic partners to translate scientific breakthroughs into life-changing treatments.

Summary

Rallybio is a Biotech company based in New Haven, United States, founded in 2018. It has raised $182.0M in total across 2 rounds, most recently a $145.0M Series B round in May 2020. Investors include Pivotal bioVenture Partners, F-Prime Capital and Viking Global.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Series BSeries BMay 2020
$145.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rallybio on Indexed.vc
<a href="https://indexed.vc/companies/rallybio"><img src="https://indexed.vc/api/badge/company/rallybio" alt="Rallybio on Indexed.vc" width="260" height="76" /></a>